plerixafor and abt-199
plerixafor has been researched along with abt-199 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, W; Li, J; Liu, X; Shi, J; Zhang, Z; Zhao, L; Zhou, Y | 1 |
Bouchlaka, MN; Capitini, CM; Cho, MM; Feils, AS; Gavcovich, TB; Hess, NJ; Kabakov, SA; Olson, SL; Quamine, AE; Rinella, SP; Rui, L; Turicek, DP; Walker, KL; Zhu, F | 1 |
Reviews
1 review(s) available for plerixafor and abt-199
Article | Year |
---|---|
A review on the treatment of multiple myeloma with small molecular agents in the past five years.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Combined Modality Therapy; Deubiquitinating Enzymes; Drug Development; Drug Resistance; Histone Deacetylases; Humans; Ikaros Transcription Factor; Immunomodulating Agents; Models, Molecular; Morpholines; Multiple Myeloma; Phthalimides; Piperidones; Proteasome Inhibitors; Treatment Outcome; Ubiquitin-Protein Ligases | 2022 |
Other Studies
1 other study(ies) available for plerixafor and abt-199
Article | Year |
---|---|
CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration.
Topics: Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System; Cyclams; Hematopoietic Stem Cell Mobilization; Humans; Janus Kinase 1; Nitriles; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Pyrimidines; Receptors, CXCR4; Sulfonamides | 2021 |